(object) array( 'id' => '1461003', 'url' => 'SR/data_safety_and_monitoring_board_(dsmb)', 'image' => '', 'title' => 'Odbor za bezbednost podataka i monitoring', 'tags' => array ( 0 => 'Odbor za bezbednost podataka i monitoring', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Odbor za bezbednost podataka i monitoring', 'source_id' => 30887, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Nezavisni odbor koji se sastoji od predstavnika udruženja i stručnjaka za klinička ispitivanja koji vrše pregled podataka u toku samog kliničkog ispitivanja radi sigurnosti da učestnici nisu izloženi nepotrebnom riziku. ovaj Odbor(DSMB)može predložiti okončanje ispitivanja ukoliko postoji sumnja u bezbedenost iii ukoliko su ciljevi ispitivanja postignuti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907777, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'data safety and monitoring board (dsmb)', 'Definition' => 'An independent committee, composed of community representatives and clinical research experts, that reviews data while a clinical trial is in progress to ensure that participants are not exposed to undue risk. A DSMB may recommend that a trial be stopped if there are safety concerns or if the trial objectives have been achieved.', 'Synonym' => 'DSMB_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'data_safety_and_monitoring_board_(dsmb)', )

(object) array( 'id' => '1461073', 'url' => 'SR/circle_skirt', 'image' => '', 'title' => 'cviklasta suknja', 'tags' => array ( 0 => 'cviklasta suknja', 1 => 'Dance', 2 => 'Belly dance', 3 => '', ), 'term' => 'cviklasta suknja', 'source_id' => 903175, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Dance', ), 'category' => array ( 0 => 'Belly dance', ), 'lastedit' => '20110705161504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'sastoji se od 3 polukružne cvikle dužine od kukova do članaka. Može se šiti posebno spreda i posebno od pozadi ili iscela', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966614700033, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'circle skirt', 'Definition' => '3 plus half circles reaching from hip to ankle. Maybe sewn as separate front and back panels or as one very full skirt.', 'Domain' => 'Documentation; Marketing', 'Industry' => 'Dance', 'Part of Speech' => 'noun', 'Product Category' => 'Belly dance', 'Usage Status' => 'New', 'Creation User' => 'cutecee12', 'Creation Date' => '2011/3/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'circle_skirt', )

(object) array( 'id' => '1461086', 'url' => 'SR/adstratum', 'image' => '', 'title' => 'adstratum', 'tags' => array ( 0 => 'adstratum', 1 => 'Language', 2 => 'Terminology', 3 => 'adposition_twgid1302883350727982', ), 'term' => 'adstratum', 'source_id' => 1066453, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Terminology', ), 'lastedit' => '20110705163517', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'jezik ili oblici jezika koji utiču na mnogo dominantnije jezike', 'usage_comment' => '', 'glossary' => 'adposition_twgid1302883350727982', 'width' => 0, 'height' => 0, '_version_' => 1503603966616797185, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'adstratum', 'Definition' => 'Language or language forms which influence more dominant languages.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Terminology', 'Creation User' => 'nunk0410', 'Creation Date' => '2011/4/15', 'Glossary' => 'adposition_twgid1302883350727982', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'adstratum', )

(object) array( 'id' => '1461006', 'url' => 'SR/orphan_drugs', 'image' => '', 'title' => 'lekovi ,,siročići\'\'', 'tags' => array ( 0 => 'lekovi ,,siročići\'\'', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'lekovi ,,siročići\'\'', 'source_id' => 30914, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kategorija Administracije za hranu i lekove koja se odnosi na lekove koji se koriste u lečenju retkih bolesti i stanja. Slabo ima finansijske motivacije za farmaceutsku industriju u pogčedu razvoja lekova za ovakve bolesti i stanja. Status lekova ,,siročića\'\', u svakom slučaju daje proizvođaču posebnu finansijsku motivaciju za razvoj i obezbeđivanje takvih lekova.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907780, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'orphan drugs', 'Definition' => 'An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. Orphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'orphan_drugs', )

(object) array( 'id' => '1461047', 'url' => 'SR/phase_i_trials', 'image' => '', 'title' => 'Prva faza ispitivanja', 'tags' => array ( 0 => 'Prva faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Prva faza ispitivanja', 'source_id' => 30916, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Početne studije sa ciljem određivanja metabolizma i farmakološkog dejstva lekova na čoveka, neželjena dejstva vezana za povećane doze, kao i sticanja ranog uvida u efikasnost leka; može uključiti ispitanike bez zdravstvenih problema odnosno pacijente.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247810, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase i trials', 'Definition' => 'Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_i_trials', )

(object) array( 'id' => '1461049', 'url' => 'SR/phase_iii_trials', 'image' => '', 'title' => 'Treća faza ispitivanja', 'tags' => array ( 0 => 'Treća faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Treća faza ispitivanja', 'source_id' => 30918, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara opšte prakse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247812, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iii trials', 'Definition' => 'Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iii_trials', )

(object) array( 'id' => '1467657', 'url' => 'SR/Lotronex', 'image' => '', 'title' => 'Lotronex', 'tags' => array ( 0 => 'Lotronex', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lotronex', 'source_id' => 31150, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju sindroma iritabilnog kolona kod žena', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845763, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lotronex', 'Definition' => 'a prescription drug used to treat IBS in women', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lotronex', )

(object) array( 'id' => '1461305', 'url' => 'SR/employee_empowerment', 'image' => '', 'title' => 'osnaživanje zaposlenih', 'tags' => array ( 0 => 'osnaživanje zaposlenih', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'osnaživanje zaposlenih', 'source_id' => 40076, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Ovaj izraz se koriti da izrazi način na koji ne-upravni sektor može doneti esencijalne odluke bez konsultacije šefa/menadžera.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967781765124, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'employee empowerment', 'Definition' => 'A term used to express the manners in which non-managerial staff can make essential decisions without consulting a boss/manager.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'employee_empowerment', )

(object) array( 'id' => '1467658', 'url' => 'SR/Merck', 'image' => '', 'title' => 'Merck', 'tags' => array ( 0 => 'Merck', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Merck', 'source_id' => 31152, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Američka farmaceutska kompanija', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845764, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Merck', 'Definition' => 'a US pharmaceutical company', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Merck', )

(object) array( 'id' => '1461308', 'url' => 'SR/performance_improvement_plan', 'image' => '', 'title' => 'plan za unapređenje radnog učinka', 'tags' => array ( 0 => 'plan za unapređenje radnog učinka', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'plan za unapređenje radnog učinka', 'source_id' => 40103, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222513', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Plan obuke koji podstiče konstruktivne diskusije između zaposlenih i nadređenih povodom načina na koji radni učinak može biti unapređen.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813697, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'performance improvement plan', 'Definition' => 'Training plan which encourages constructive discussion between employees and supervisors regarding how work performance can be improved.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'performance_improvement_plan', )